IRadimed Corporation Announces Fourth Quarter 2015 Financial Results

WINTER SPRINGS, Fla., Feb. 05, 2016 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three months and full year ended December 31, 2015.

For the fourth quarter ended December 31, 2015, the Company reported revenue of $8.8 million, an increase of 145.5% compared to $3.6 million for the fourth quarter of 2014. Net income was $2.4 million, or $0.19 per diluted share, compared with net income of $0.3 million, or $0.02 per diluted share for the fourth quarter of 2014.

Back to news